Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
Fady C, Gardner AM, Gera JF, Lichtenstein A.
Cancer Res. 1992 Feb 15;52(4):764-9.
PMID:1346583
Epithelial ovarian cancer stem-like cells are resistant to the cellular lysis of cytokine-induced killer cells via HIF1A-mediated downregulation of ICAM-1.
Bu S, Li B, Wang Q, Gu T, Dong Q, Miao X, Lai D.
Int J Oncol. 2019 Jul;55(1):179-190. doi: 10.3892/ijo.2019.4794. Epub 2019 May 3.
PMID:31059002
Laparoscopic surgery in endometriosis.
Eltabbakh GH, Bower NA.
Minerva Ginecol. 2008 Aug;60(4):323-30.
PMID:18560348
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity.
Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Cannistra S, Avigan D, Kufe D.
J Immunol. 2000 Aug 1;165(3):1705-11. doi: 10.4049/jimmunol.165.3.1705.
PMID:10903782
Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian cancer cell lines.
Yashar CM, Taylor DD, Gibb RK, Gerçel-Taylor C.
Am J Reprod Immunol. 1997 Dec;38(6):431-7. doi: 10.1111/j.1600-0897.1997.tb00323.x.